What is known about the safety of canakinumab during pregnancy?

Canakinumab pregnancy data are limited and fetal/maternal risk is unknown; animal studies show no direct or indirect reproductive harm, but human placental transfer is expected with unknown clinical impact, so pregnant women or those planning pregnancy should receive treatment only after thorough benefit-risk evaluation.